Skip to main content
Top
Published in: Acta Diabetologica 2/2017

01-02-2017 | Original Article

Are all people with diabetes and cardiovascular risk factors or microvascular complications at very high risk? Findings from the Risk and Prevention Study

Authors: Irene Marzona, Fausto Avanzini, Giuseppe Lucisano, Mauro Tettamanti, Marta Baviera, Antonio Nicolucci, Maria Carla Roncaglioni, Risk & Prevention Collaborative Group

Published in: Acta Diabetologica | Issue 2/2017

Login to get access

Abstract

Aims

To verify whether it is possible, in people with diabetes mellitus (DM) considered at very high cardiovascular (CV) risk, stratify this risk better and identify significant modifiable risk factor (including lifestyle habits) to help patients and clinicians improve CV prevention.

Methods

People with DM and microvascular diseases or one or more CV risk factors (hypertension, hyperlipidemia, smoking, poor dietary habits, overweight, physical inactivity) included in the Risk and Prevention study were selected. We considered the combined endpoint of non-fatal acute myocardial infarction and stroke and CV death. A multivariate Cox proportional analysis was carried out to identify relevant predictors. We also used the RECPAM method to identify subgroups of patients at higher risk.

Results

In our study, the rate of major CV events was lower than expected (5 % in 5 years). Predictors of CV events were age, male, sex, heart failure, previous atherosclerotic disease, atrial fibrillation, insulin treatment, high HbA1c, heart rate and other CV diseases while being physically active was protective. RECPAM analysis indicated that history of atherosclerotic diseases and a low BMI defined worse prognosis (HR 4.51 95 % CI 3.04–6.69). Among subjects with no previous atherosclerotic disease, men with HbA1c more than 8 % were at higher CV risk (HR 2.77; 95 % CI 1.86–4.14) with respect to women.

Conclusions

In this population, the rate of major CV events was lower than expected. This prediction model could help clinicians identify people with DM at higher CV risk and support them in achieving goals of physical activity and HbA1c.
Appendix
Available only for authorised users
Literature
2.
go back to reference Monesi L, Tettamanti M, Cortesi L et al (2014) Elevated risk of death and major cardiovascular events in subjects with newly diagnosed diabetes: findings from an administrative database. Nutr Metab Cardiovasc Dis 24:263–270CrossRefPubMed Monesi L, Tettamanti M, Cortesi L et al (2014) Elevated risk of death and major cardiovascular events in subjects with newly diagnosed diabetes: findings from an administrative database. Nutr Metab Cardiovasc Dis 24:263–270CrossRefPubMed
3.
go back to reference Donnan PT, Donnelly L, New JP, Morris AD (2006) Derivation and validation of prediction score for major coronary heart disease events in a UK type 2 diabetic population. Diabetes Care 29:1231–1236CrossRefPubMed Donnan PT, Donnelly L, New JP, Morris AD (2006) Derivation and validation of prediction score for major coronary heart disease events in a UK type 2 diabetic population. Diabetes Care 29:1231–1236CrossRefPubMed
4.
5.
go back to reference Yang X, So WY, Kong APS et al (2008) Development and validation of a total coronary heart disease risk score in type 2 diabetes mellitus. Am J Cardiol 101:596–601CrossRefPubMed Yang X, So WY, Kong APS et al (2008) Development and validation of a total coronary heart disease risk score in type 2 diabetes mellitus. Am J Cardiol 101:596–601CrossRefPubMed
6.
go back to reference Kengne AP, Patel A, Marre M et al (2011) Contemporary model for cardiovascular risk prediction in people with type 2 diabetes. Eur J Cardiovasc Prev Rehabil 18:393–398CrossRefPubMed Kengne AP, Patel A, Marre M et al (2011) Contemporary model for cardiovascular risk prediction in people with type 2 diabetes. Eur J Cardiovasc Prev Rehabil 18:393–398CrossRefPubMed
7.
go back to reference Elley CR, Robinson E, Kenealy T, Bramley D, Drury PL (2010) Derivation and validation of a new cardiovascular risk score for people with type 2 diabetes. Diabetes Care 33:1347–1352CrossRefPubMedPubMedCentral Elley CR, Robinson E, Kenealy T, Bramley D, Drury PL (2010) Derivation and validation of a new cardiovascular risk score for people with type 2 diabetes. Diabetes Care 33:1347–1352CrossRefPubMedPubMedCentral
8.
go back to reference Stevens RJ, Kothari V, Adler AI, Stratton IM, Holman RR (2001) The UKPDS risk engine: a model for the risk of coronary heart disease in type II diabetes (UKPDS 56). Clin Sci 101:671–679CrossRefPubMed Stevens RJ, Kothari V, Adler AI, Stratton IM, Holman RR (2001) The UKPDS risk engine: a model for the risk of coronary heart disease in type II diabetes (UKPDS 56). Clin Sci 101:671–679CrossRefPubMed
9.
go back to reference Piniés JA, González-Carril F, Artegoitia JM et al (2014) Development of a prediction model for fatal and non-fatal coronary heart disease and cardiovascular disease in patients with newly diagnosed type 2 diabetes mellitus: the Basque Country Prospective Complication and Mortality Study risk engine (BASCORE). Diabetologia 57:2324–2333CrossRefPubMed Piniés JA, González-Carril F, Artegoitia JM et al (2014) Development of a prediction model for fatal and non-fatal coronary heart disease and cardiovascular disease in patients with newly diagnosed type 2 diabetes mellitus: the Basque Country Prospective Complication and Mortality Study risk engine (BASCORE). Diabetologia 57:2324–2333CrossRefPubMed
10.
go back to reference Zhetelius B, Eliasson B, Eeg-Olofsson K et al (2011) A new model for 5-year risk of cardiovascular disease in type 2 diabetes, from the Swedish National Diabetes Register (NDR). Diabetes Res Clin Pract 93:276–284CrossRef Zhetelius B, Eliasson B, Eeg-Olofsson K et al (2011) A new model for 5-year risk of cardiovascular disease in type 2 diabetes, from the Swedish National Diabetes Register (NDR). Diabetes Res Clin Pract 93:276–284CrossRef
11.
go back to reference Davis WA, Knuiman MW, Davis ME (2010) An Australian cardiovascular risk equation for type 2 diabetes: the Fremantle Diabetes Study. Intern Med J 40:286–292CrossRefPubMed Davis WA, Knuiman MW, Davis ME (2010) An Australian cardiovascular risk equation for type 2 diabetes: the Fremantle Diabetes Study. Intern Med J 40:286–292CrossRefPubMed
12.
go back to reference D’Agostino RB, Wolf PA, Belanger AJ, Kannel WB (1994) Stroke risk profile: adjustment for antihypertensive medication. The Framingham Study. Stroke 25:40–43CrossRefPubMed D’Agostino RB, Wolf PA, Belanger AJ, Kannel WB (1994) Stroke risk profile: adjustment for antihypertensive medication. The Framingham Study. Stroke 25:40–43CrossRefPubMed
13.
go back to reference Kothari V, Stevens RJ, Adler AI et al (2002) UKPDS 60: risk of stroke in type 2 diabetes estimated by the UK prospective diabetes study risk engine. Stroke 33:1776–1781CrossRefPubMed Kothari V, Stevens RJ, Adler AI et al (2002) UKPDS 60: risk of stroke in type 2 diabetes estimated by the UK prospective diabetes study risk engine. Stroke 33:1776–1781CrossRefPubMed
14.
go back to reference Yang X, So WY, King APS et al (2007) Development and validation of stroke risk equation for Hong Kong chinese patients with type 2 diabetes. Diabetes Care 30:65–70CrossRefPubMed Yang X, So WY, King APS et al (2007) Development and validation of stroke risk equation for Hong Kong chinese patients with type 2 diabetes. Diabetes Care 30:65–70CrossRefPubMed
15.
go back to reference The Task Force on diabetes, pre-diabetes, and cardiovascular diseases of The European Society of Cardiology (ESC)and developed in collaboration with the European Association for the Study of Diabetes (EASD) (2013) ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur Heart J 34:3035–3087CrossRef The Task Force on diabetes, pre-diabetes, and cardiovascular diseases of The European Society of Cardiology (ESC)and developed in collaboration with the European Association for the Study of Diabetes (EASD) (2013) ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur Heart J 34:3035–3087CrossRef
17.
go back to reference The Risk and Prevention Study Collaborative Group (2013) N-3 fatty acids in patients with multiple cardiovascular risk factors. N Engl J Med 368:1800–1808CrossRef The Risk and Prevention Study Collaborative Group (2013) N-3 fatty acids in patients with multiple cardiovascular risk factors. N Engl J Med 368:1800–1808CrossRef
18.
go back to reference Ciampi A (1992) Constructing prediction trees from data: the RECPAM approach Proceedings from the Prague 1991 summer school on computational aspects of model choice. Physica, Heidelberg, pp 165–178 Ciampi A (1992) Constructing prediction trees from data: the RECPAM approach Proceedings from the Prague 1991 summer school on computational aspects of model choice. Physica, Heidelberg, pp 165–178
20.
go back to reference Pintaudi B (2014) Improvement of selective screening strategy for gestational diabetes through a more accurate definition of high-risk groups. Eur J Endocr 170:87–93CrossRef Pintaudi B (2014) Improvement of selective screening strategy for gestational diabetes through a more accurate definition of high-risk groups. Eur J Endocr 170:87–93CrossRef
22.
go back to reference Rana JS, Liu JY, Moffet HH et al (2015) Diabetes and prior coronary heart disease are not necessarily risk equivalent for future coronary heart disease events. J Gen Intern Med 31:387–393CrossRefPubMed Rana JS, Liu JY, Moffet HH et al (2015) Diabetes and prior coronary heart disease are not necessarily risk equivalent for future coronary heart disease events. J Gen Intern Med 31:387–393CrossRefPubMed
23.
go back to reference Baviera M, Cortesi L, Tettamanti M et al (2014) Changes in prescribing patterns and clinical outcomes in elderly diabetic patients in 2000 and 2010: analysis of a large Italian population-based study. Eur J Clin Pharmacol 70:965–974CrossRefPubMed Baviera M, Cortesi L, Tettamanti M et al (2014) Changes in prescribing patterns and clinical outcomes in elderly diabetic patients in 2000 and 2010: analysis of a large Italian population-based study. Eur J Clin Pharmacol 70:965–974CrossRefPubMed
24.
go back to reference Gesrtein HC, Swedberg K, Carlosson J et al (2008) The hemoglobin A1c level as progressive risk factor for cardiovascular death, hospitalization for heart failure, or death in patients with chronic heart failure. Arch Intern Med 168:1699–1704CrossRef Gesrtein HC, Swedberg K, Carlosson J et al (2008) The hemoglobin A1c level as progressive risk factor for cardiovascular death, hospitalization for heart failure, or death in patients with chronic heart failure. Arch Intern Med 168:1699–1704CrossRef
25.
go back to reference Erkström N, Schiöler L, Svensson AM et al (2012) Effectiveness and safety of metformin in 51675 patients with type 2 diabetes and different levels of renal function: a cohort study from the Swedish National Diabetes Register. BMJ Open 2:e001076. doi:10.1136/bmjopen-2012-001076 CrossRef Erkström N, Schiöler L, Svensson AM et al (2012) Effectiveness and safety of metformin in 51675 patients with type 2 diabetes and different levels of renal function: a cohort study from the Swedish National Diabetes Register. BMJ Open 2:e001076. doi:10.​1136/​bmjopen-2012-001076 CrossRef
26.
go back to reference Gamble JM, Simpson SH, Eurich DT, Majumdar SR, Johnson JA (2010) Insulin use and increased risk of mortality in type 2 diabetes: a cohort study. Diabetes Obes Metab 12:47–53CrossRefPubMed Gamble JM, Simpson SH, Eurich DT, Majumdar SR, Johnson JA (2010) Insulin use and increased risk of mortality in type 2 diabetes: a cohort study. Diabetes Obes Metab 12:47–53CrossRefPubMed
27.
go back to reference Sluik D, Buijsse B, Muckelbauer R et al (2012) Physical activity and mortality in individuals with diabetes mellitus. Arch Intern Med 172:1285–1295CrossRefPubMed Sluik D, Buijsse B, Muckelbauer R et al (2012) Physical activity and mortality in individuals with diabetes mellitus. Arch Intern Med 172:1285–1295CrossRefPubMed
28.
go back to reference Ravnskov U, Diamond DM, Hama R et al (2016) Lack of an association or an inverse association between low-density-lipoprotein cholesterol and mortality in the elderly: a systematic review. BMJ Open 6:e010401CrossRefPubMedPubMedCentral Ravnskov U, Diamond DM, Hama R et al (2016) Lack of an association or an inverse association between low-density-lipoprotein cholesterol and mortality in the elderly: a systematic review. BMJ Open 6:e010401CrossRefPubMedPubMedCentral
Metadata
Title
Are all people with diabetes and cardiovascular risk factors or microvascular complications at very high risk? Findings from the Risk and Prevention Study
Authors
Irene Marzona
Fausto Avanzini
Giuseppe Lucisano
Mauro Tettamanti
Marta Baviera
Antonio Nicolucci
Maria Carla Roncaglioni
Risk & Prevention Collaborative Group
Publication date
01-02-2017
Publisher
Springer Milan
Published in
Acta Diabetologica / Issue 2/2017
Print ISSN: 0940-5429
Electronic ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-016-0899-0

Other articles of this Issue 2/2017

Acta Diabetologica 2/2017 Go to the issue